Allergies News and Research

Latest Allergies News and Research

Researchers demonstrate direct transfer of terminally differentiated cell nuclei

With the advent of nuclear-transfer cloning, it is now possible to produce mice from the nuclei of differentiated cells, such as peripheral blood lymphocytes and olfactory sensory neurons.

20 Jun 2005

Australian scientists develop unique animal model for asthma

The State Government of Victoria, Australia has announced that Melbourne veterinary scientists have developed a unique animal model for asthma that may help drug companies fast track the creation of therapies for the disease.

19 Jun 2005

Immune system discovery could help in the treatment of bowel cancer

Scientists investigating whipworms, parasites that infect one-fifth of the world's population as well as livestock and domestic animals, have discovered a new way that the body effectively eliminates the parasites.

From The University of Manchester 16 Jun 2005

Vical receives $12 Million HIV vaccine order

Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.

16 Jun 2005

Antifungal drug could improve lives of thousands of asthmatics

Researchers in the UK say that antifungal drugs could be the key to improving the lives of thousands of asthmatics.

From The University of Manchester 16 Jun 2005

Promising new tuberculosis drug enters clinical trial

A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced this week.

15 Jun 2005

Key milestone in study of the antifungal treatment of asthma

University of Manchester researchers announced today that they have reached a key milestone in their study of the antifungal treatment of asthma.

From The University of Manchester 15 Jun 2005

Non-profit public-private partnership develops affordable, new drug regimens for tuberculosis

The Global Alliance for TB Drug Development (TB Alliance), a non-profit public-private partnership developing affordable, new drug regimens for tuberculosis, today announced the start of Phase I clinical trials for the lead TB drug in its pipeline, PA-824. The trials begin this month.

14 Jun 2005

Claritin's switch to OTC status meant fewer prescriptions

After the allergy drug Claritin became available without a prescription in 2002, insurance plans and consumers spent less on the prescription form of its main ingredient, loratadine, and all similar allergy drugs, according to a new report published in this month’s The American Journal of Managed Care.

10 Jun 2005

AIDS expert says global strategy needed to combat feminization of HIV/AIDS

Thomas C. Quinn, M.D., a Johns Hopkins physician and scientist, who has spent the best part of the last 25 years leading major efforts to combat HIV and AIDS throughout the world, is calling for global strategies and resources to confront the rapid "feminization" of the AIDS pandemic.

10 Jun 2005

Researchers discover how hepatic-C virus evades immune system in acute and chronic infections

Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection.

10 Jun 2005

Urgent call for global strategies and resources to confront the rapid "feminization" of the AIDS pandemic

In an article appearing in the journal Science online June 10, Thomas C. Quinn, M.D., professor of infectious diseases at Hopkins and a senior investigator at the National Institute of Allergy and Infectious Disease, reports that women have in the last 20 years moved from those least affected by HIV to those in whom the disease is spreading fastest.

10 Jun 2005

Researchers determine potentially safer way to diagnose food allergy

Researchers may have defined a safer and less expensive way to determine the presence of food allergy in children, according to new research in the Journal of Allergy & Clinical Immunology (JACI). The JACI is the peer-reviewed scientific journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

9 Jun 2005

Prototype drug shows promise in slowing replication of the virus responsible for SARS

A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS.

8 Jun 2005

New process removes allergy potential from peanut products

Scientists say a special fermentation process may significantly reduce the potential for allergic reaction to peanut products.

6 Jun 2005

World first air purification technology for H5N1 Avian Influenza

Sharp Corporation has demonstrated that Plasmacluster Ions reduce activity of the highly fatal and highly pathogenic airborne H5N1 avian influenza ("bird flu") virus by 99%.

6 Jun 2005

Novel insights into how prion and other neurodegenerative diseases develop

Abnormal prion proteins are little understood disease agents involved in causing horrific brain-wasting diseases such as Creutzfeldt-Jacob disease in people, mad cow disease in cattle and chronic wasting disease in deer and elk.

3 Jun 2005

Most doctors and patients misbelieve that a nebulizer is more effective than an inhaler for asthma

Battling a child’s asthma attack could be as simple as sliding a plastic tube onto the end of an inhaler, but many health-care providers don’t offer this option to parents, say University of Florida researchers, who are calling for change.

2 Jun 2005

Intervention program reduces asthma in children

An asthma intervention program applied during the first year of life significantly reduced the prevalence of asthma in high risk children at 7 years of age, according to a new study featured on the online version of the Journal of Allergy & Clinical Immunology (JACI). The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

2 Jun 2005

Day care facilities were shown to be an important source for allergen exposure

Day care facilities were shown to be an important source for allergen exposure, according to a study featured on the online version of the Journal of Allergy & Clinical Immunology (JACI). The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

2 Jun 2005